ReviewSeminars in immunopathology2007
B cells in glomerulonephritis: focus on lupus nephritis.
Review in Seminars in immunopathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 22 citations in OpenAlex.
- Can we cure autoimmunity?Current opinion in immunology · 2026Review
- Identification of driver genes in lupus nephritis based on comprehensive bioinformatics and machine learning.Frontiers in immunology · 2023Article
- Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis.JCI insight · 2022Article
- Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis.Proceedings of the National Academy of Sciences of the United States of America · 2020Article
- Fcγ Receptors in Solid Organ Transplantation.Current transplantation reports · 2016Review
- Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice.Immunology · 2013Article
- B-cell depletion in the treatment of lupus nephritis.Nature reviews. Nephrology · 2012Review
- Thymic stromal lymphopoietin (TSLP)-induced polyclonal B-cell activation and autoimmunity are mediated by CD4+ T cells and IL-4.International immunology · 2012Article
- Biological therapy for lupus nephritis-tribulations and trials.Nature reviews. Rheumatology · 2010Review
- Neutrophils: game changers in glomerulonephritis?Trends in molecular medicine · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The production of pathogenic antibody has been traditionally viewed as the principle contribution of B cells to the pathogenesis of immune-mediated glomerulonephritis. However, it is increasingly appreciated that B cells play a much broader role in such diseases, functioning as antigen-presenting cells, regulators of T cells, dendritic cells, and macrophages and orchestrators of local lymphatic expansion. In this review, we provide an overview of basic B cell biology and consider the evidence implicating B cells in one of the archetypal immune-mediated glomerulonephritides, lupus nephritis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.